Changes in markers of oxidative stress and DNA damage in human visceral adipose tissue from subjects with obesity and type 2 diabetes

Diabetes Research and Clinical Practice

Volumn 106, Issue 3, 2014, Pages 627-633

  Jones, D A ^a   Prior, S L ^a   Barry, J D ^b   Caplin, S ^b   Baxter, J N ^b   Stephens, J W ^a,b  

^a SWANSEA UNIVERSITY   (United Kingdom)

^b MORRISTON HOSPITAL   (United Kingdom)

Author keywords

Obesity; Oxidative stress; Type 2 diabetes mellitus

Indexed keywords

MALONALDEHYDE; THIOBARBITURIC ACID REACTIVE SUBSTANCE; ANTIOXIDANT; BIOLOGICAL MARKER; DNA;

ADULT; AGED; ARTICLE; COMET ASSAY; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA DAMAGE; HUMAN; HUMAN TISSUE; INTRAABDOMINAL FAT; LIPID PEROXIDATION; MAJOR CLINICAL STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; OXIDATIVE STRESS; TELOMERE HOMEOSTASIS; VERY ELDERLY; ADIPOSE TISSUE; ADOLESCENT; COMPLICATION; FEMALE; GENETICS; MALE; METABOLISM; MIDDLE AGED; POLYMERASE CHAIN REACTION; RETROSPECTIVE STUDY; YOUNG ADULT;

ADIPOSE TISSUE; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIOXIDANTS; BIOMARKERS; DIABETES MELLITUS, TYPE 2; DNA; DNA DAMAGE; FEMALE; HUMANS; INTRA-ABDOMINAL FAT; LIPID PEROXIDATION; MALE; MALONDIALDEHYDE; MIDDLE AGED; OBESITY; OXIDATIVE STRESS; POLYMERASE CHAIN REACTION; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84920655345     PISSN: 01688227     EISSN: 18728227     Source Type: Journal    
DOI: 10.1016/j.diabres.2014.09.054     Document Type: Article

References (34)

1. Rennie K., Jebb S. National prevalence of obesity: prevalence of obesity in Great Britain. Obes Rev 2005, 6:11-12.
2. Codoner P., Valls-Belles V., Arilla-Codoner A., Alonso-Iglasias E. Oxidant mechanisms in childhood obesity: the link between inflammation and oxidative stress. Transl Res 2011, 158:369-384.
3. Rehman A., Nourooz-Zadeh J., Moller W., Tritschler H., Pereira P., Halliwell B. Increased oxidative damage to all DNA bases in patients with type II diabetes mellitus. FEBS Lett 1999, 448:120-122.
4. Apelt N., da Silva A.P., Ferreira J., Alho I., Monteiro C., Marinho C., et al. ACP1 genotype, glutathione reductase activity, and riboflavin uptake affect cardiovascular risk in the obese. Metabolism 2009, 58:1415-1423.
5. Tatsch E., Bochi G.V., Piva S.J., De Carvalho J.A., Kober H., Torbitz V.D., et al. Association between DNA strand breakage and oxidative, inflammatory and endothelial biomarkers in type 2 diabetes. Mutat Res 2012, 732:16-20.
6. Mauricio M.D., Aldasoro M., Ortega J., Vila J.M. Endothelial dysfunction in morbid obesity. Curr Pharm Des 2013, 19:5718-5729.
7. Brandes R.P., Janiszewski M. Direct detection of reactive oxygen species ex vivo. Kidney Int 2005, 67:1662-1664.
8. Monickaraj F., Aravind S., Nandhini P., Prabu P., Sathishkumar C., Mohan V., et al. Accelerated fat cell aging links oxidative stress and insulin resistance in adipocytes. J Biosci 2013, 38:113-122.
9. Minamino T., Komuro I. Vascular cell senescence: contribution to atherosclerosis. Circ Res 2007, 100:15-26.
10. Monickaraj F., Aravind S., Gokulakrishnan K., Sathishkumar C., Prabu P., Prabu D., et al. Accelerated aging as evidenced by increased telomere shortening and mitochondrial DNA depletion in patients with type 2 diabetes. Mol Cell Biochem 2012, 365:343-350.
11. Cawthon R.M. Telomere measurement by quantitative PCR. Nucleic Acids Res 2002, 30:e47.
12. Collins A.R., Raslova K., Somorovska M., Petrovska H., Ondrusova A., Vohnout B., et al. DNA damage in diabetes: correlation with a clinical marker. Free Radical Biol Med 1998, 25:373-377.
13. Lodovici M., Giovannelli L., Pitozzi V., Bigagli E., Bardini G., Rotella C.M. Oxidative DNA damage and plasma antioxidant capacity in type 2 diabetic patients with good and poor glycaemic control. Mutat Res 2008, 638:98-102.
14. Dincer Y., Alademir Z., Ilkova H., Akcay T. Susceptibility of glutatione and glutathione-related antioxidant activity to hydrogen peroxide in patients with type 2 diabetes: effect of glycemic control. Clin Biochem 2002, 35:297-301.
15. Helmersson J., Vessby B., Larsson A., Basu S. Association of type 2 diabetes with cyclooxygenase-mediated inflammation and oxidative stress in an elderly population. Circulation 2004, 109:1729-1734.
16. Furukawa S., Fujita T., Shimabukuro M., Iwaki M., Yamada Y., Nakajima Y., et al. Increased oxidative stress in obesity and its impact on metabolic syndrome. J Clin Invest 2013, 114:1752-1761.
17. Sturgeon K.M., Feairheller D.L., Diaz K.M., Williamson S.T., Veerabhadrappa P., Brown M.D. Clinical risk factors demonstrate an age-dependent relationship with oxidative stress biomarkers in African Americans. Ethn Dis 2010, 20:403-408.
18. Zglinicki T. Oxidative stress shortens telomeres. Trends Biochem Sci 2002, 27:7.
19. Salpea K.D., Talmud P.J., Cooper J.A., Maubaret C.G., Stephens J.W., Abelak K., et al. Association of telomere length with type 2 diabetes, oxidative stress and UCP2 gene variation. Atherosclerosis 2010, 209:42-50.
20. Lee M., Martin H., Firpo M.A., Demerath E.W. Inverse association between adiposity and telomere length: The Fels Longitudinal study. Am J Hum Biol 2011, 23:100-106.
21. Houben J.M., Moonen H.J., van Schooten F.J., Hageman G.J. Telomere length assessment: biomarker of chronic oxidative stress?. Free Radical Biol Med 2008, 44:235-246.
22. Astrup A.S., Tarnow L., Jorsal A., Lajer M., Nzietchueng R., Benetos A., et al. Telomere length predicts all-cause mortality in patients with type 1 diabetes. Diabetologia 2010, 53:45-48.
23. Sanchez-Espiridion B., Chen M., Chang J.Y., Lu C., Chang D.W., Roth J.A., et al. Telomere length in peripheral blood leukocytes and lung cancer risk: a large case-control study in Caucasians. Cancer Res 2014, 74:2476-2486.
24. Maubaret C.G., Salpea K.D., Jain A., Cooper J.A., Hamsten A., Sanders J., et al. Telomeres are shorter in myocardial infarction patients compared to healthy subjects: correlation with environmental risk factors. J Mol Med (Berl) 2010, 88:785-794.
25. Moreno-Navarrete J.M., Ortega F., Sabater M., Ricart W., Fernández-Real J.M. Telomere length of subcutaneous adipose tissue cells is shorter in obese and formerly obese subjects. Int J Obes (Lond) 2010, 34:1345-1348.
26. Monickaraj F., Gokulakrishnan K., Prabu P., Sathishkumar C., Anjana R.M., Rajkumar J.S., et al. Convergence of adipocyte hypertrophy, telomere shortening and hypoadiponectinemia in obese subjects and in patients with type 2 diabetes. Clin Biochem 2012, 45:1432-1438.
27. Saliques S., Teyssier J.R., Vergely C., Lorgis L., Lorin J., Farnier M., et al. Circulating leukocyte telomere length and oxidative stress: a new target for statin therapy. Atherosclerosis 2011, 219:753-760.
28. Ibarra-Costilla E., Cerda-Flores R.M., Davila-Rodriguez M.I., Samayo-Reyes A., Calzado-Flores C., Cortes-Gutierrez E.I. DNA damage evaluated by Comet assay in Mexican patients with type 2 diabetes mellitus. Acta Diabetol 2010, 47(Suppl (1)):111-116.
29. Sliwinska A., Blasiak J., Kasznicki J., Drzewoski J. In vitro effect of gliclazide on DNA damage and repair in patients with type 2 diabetes mellitus (T2DM). Chem Biol Interact 2008, 173:159-165.
30. Bukhari S.A., Rajoka M.I., Nagra S.A., Rehman Z.U. Plasma homocysteine and DNA damage profiles in normal and obese subjects in the Pakistani population. Mol Biol Rep 2010, 37:289-295.
31. Blasiak J., Arabski M., Krupa R., Wozniak K., Zadrozny M., Kasznicki J., et al. DNA damage and repair in type 2 diabetes mellitus. Mutat Res 2004, 554:297-304.
32. Thakkar N.V., Jain S.M. A comparative study of DNA damage in patients suffering from diabetes and thyroid dysfunction and complications. Clin Pharmacol 2010, 2:199-205.
33. Manfredini V., Biancini G.B., Vanzin C.S., Dal Vesco A.M., Cipriani F., Biasi L., et al. Simvastatin treatment prevents oxidative damage to DNA in whole blood leukocytes of dyslipidemic type 2 diabetic patients. Cell Biochem Funct 2010, 28:360-366.
34. Shin M.J., Cho E.Y., Jang Y., Lee J.H., Shim W.H., Cho S.Y., et al. A beneficial effect of simvastatin on DNA damage in 242T allele of the NADPH oxidase p22phox in hypercholesterolemic patients. Clin Chim Acta 2005, 360:46-51.